Stabenow Elaine, Tavares Marcos Roberto, Ab'Saber Alexandre Muxfeldt, Parra-Cuentas Edwin Roger, de Matos Leandro Luongo, Eher Esmeralda Miristene, Capelozzi Vera Luiza, Ferraz Alberto Rosseti
Head and Neck Surgery Department and Pathology Department, Hospital das Clínicas, Faculty of Medicine, University of São Paulo São Paulo, São Paulo, SP, Brazil.
Clinics (Sao Paulo). 2005 Jun;60(3):233-40. doi: 10.1590/s1807-59322005000300009. Epub 2005 Jun 13.
Angiogenesis is new blood vessel formation, a process that can lead to tumor development. Microvessel count has been correlated to metastasis in some neoplasias.
To determine if measurement of microvessel density is useful in predicting metastasis to the cervical lymph node and prognosis in patients with papillary thyroid carcinoma.
A retrospective analysis was performed in 30 patients that had undergone total thyroidectomy. They were divided in 2 groups of 15 patients--with and without metastatic disease. Immunohistochemistry was used to detect expression of CD34 in archival paraffin-embedded papillary thyroid tumors, and microvessel density was calculated based on it. Association between microvessel density and the presence of metastasis, according to histological subtype, disease recurrence, and AMES prognostic index groups was determined through statistical analysis.
The median microvessel density for the patient group without metastasis (200.0 microvessels/mm2) was apparently, but not significantly, less than that observed among metastatic disease patients (254.4 microvessels/mm2) (P=.20). When papillary carcinoma subtypes were analyzed, this difference became significant (P=02). The follicular variant exhibited a greater microvessel density than the other subtypes, independent of metastasis presence. There was an apparent, but not significant, tendency for a larger median microvessel density in the group of patients that presented recurrence (294.4 microvessels/mm2 vs 249.6 microvessels/mm2, P=.11). There was no relationship between risk level and microvessel density: in the low- and high-risk groups, the median MVD was 304.0 microvessels/mm2 and 229.6 microvessels/mm2, respectively (P=.27).
The results suggest that angiogenesis is more intense among metastatic tumors in the classic and the tall cell variants, indicating that microvessel count can be an indicator of the potential for metastasis in these subtypes of papillary thyroid carcinoma. Patients that developed recurrent disease had a tendency to exhibit higher angiogenesis; however, there was no association between microvessel density and the AMES prognostic index.
血管生成是新血管形成的过程,该过程可导致肿瘤发展。微血管计数在某些肿瘤中已与转移相关。
确定微血管密度测量是否有助于预测甲状腺乳头状癌患者颈部淋巴结转移及预后。
对30例行全甲状腺切除术的患者进行回顾性分析。他们被分为两组,每组15例——有转移疾病组和无转移疾病组。采用免疫组织化学法检测存档石蜡包埋的甲状腺乳头状肿瘤中CD34的表达,并据此计算微血管密度。通过统计分析确定微血管密度与转移的存在、组织学亚型、疾病复发和AMES预后指数组之间的关联。
无转移患者组的微血管密度中位数(200.0个微血管/mm²)明显低于转移疾病患者组(254.4个微血管/mm²),但差异无统计学意义(P = 0.20)。分析乳头状癌亚型时,这种差异具有统计学意义(P = 0.02)。滤泡样变体的微血管密度高于其他亚型,与转移的存在无关。复发患者组的微血管密度中位数有明显但无统计学意义的升高趋势(294.4个微血管/mm²对249.6个微血管/mm²,P = 0.11)。风险水平与微血管密度之间无相关性:低风险和高风险组的微血管密度中位数分别为304.0个微血管/mm²和229.6个微血管/mm²(P = 0.27)。
结果表明,经典型和高细胞变体的转移瘤中血管生成更为强烈,这表明微血管计数可作为这些亚型甲状腺乳头状癌转移潜能的指标。发生复发性疾病的患者往往表现出更高的血管生成;然而,微血管密度与AMES预后指数之间无关联。